Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024
Author:
Top Cited Papers
- 28 August 2024
- journal article
- review article
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (1) , 102406
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Early detection and prognosis evaluation for hepatocellular carcinoma by circulating tumour DNA methylation: A multicentre cohort studyClinical and Translational Medicine, 2024
- Gender dimorphism in hepatocarcinogenesis—DNA methylation modification regulated X‐chromosome inactivation escape molecule XISTClinical and Translational Medicine, 2023
- Multi-center prospective survey of hepatocellular carcinoma in Kerala: More than 1,200 casesIndian Journal of Gastroenterology, 2023
- Etiologic fractions in patients of hepatocellular carcinoma in India with and without a background of cirrhosis: a multi-centric studyHepatology International, 2023
- Clinical and demographic predictors of survival for fibrolamellar carcinoma patients—A patient community, registry‐based studyHepatology Communications, 2022
- Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019Cancer Medicine, 2022
- Is hepatocellular carcinoma the same disease in children and adults? Comparison of histology, molecular background, and treatment in pediatric and adult patientsPediatric Blood & Cancer, 2018
- 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT)Pediatric Radiology, 2018
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infectionHepatology, 2012
- Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic ReviewJournal of General Internal Medicine, 2012